Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease (Métaux/Poumons)

This study has been completed.
Information provided by (Responsible Party):
Hopital Foch Identifier:
First received: September 19, 2013
Last updated: May 2, 2016
Last verified: May 2016
Prospective research to study the relationship between concentrations of metals/metalloids in blood, hair and lung tissue with the occurence of lung cancer or chronic obstructive pulmonary disease.

Condition Intervention
Lung Cancer
Chronic Obstructive Pulmonary Disease
Lung Surgery
Procedure: Lung surgery

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Relationship Between Blood, Hair and Lung Metals/Metalloids Concentration (Cadmium, Iron, Copper, Nickel, Chrome, Arsenic, Vanadium, Beryllium, and Zinc) and Lung Cancer or Chronic Obstructive Pulmonary Disease.

Resource links provided by NLM:

Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • Metals/metalloids concentration [ Time Frame: Blood, hair and lung tissue are sampled during lung surgery ] [ Designated as safety issue: No ]

Enrollment: 251
Study Start Date: August 2011
Study Completion Date: March 2014
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Pulmonary cancer Procedure: Lung surgery


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients of 18 to 75 years of age.
  • Patients admitted for lung resection (either cancerous or non-cancerous) or lung transplant

Exclusion Criteria:

  • Patients with mental or physical conditions that prevent them giving their agreement for the study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01949181

Hopital Foch
Suresnes, Ile de France, France, 92150
CHU de Poitiers, Chirurgie Cardiaque et Thoracique
Poitiers, France, 86000
Sponsors and Collaborators
Hopital Foch
Study Chair: Stanislas Grassin Delyle Hôpital Foch
  More Information

Responsible Party: Hopital Foch Identifier: NCT01949181     History of Changes
Other Study ID Numbers: 2010/37 
Study First Received: September 19, 2013
Last Updated: May 2, 2016
Health Authority: France: Agence Nationale de Sécurité du Médicament et des produits de santé

Keywords provided by Hopital Foch:
Lung cancer
Chronic obstructive pulmonary disease

Additional relevant MeSH terms:
Lung Neoplasms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Pathologic Processes processed this record on October 21, 2016